Agno Pharmaceuticals is a US-headquartered end-to-end global CDMO
90+
Scientists
15+
PhDs
60+
Quality Professionals
200+
Production Personnel
500+
Total Headcount
Agno Pharmaceuticals: Your Trusted Global Partner in CDMO Solutions
Established in 2004, Agno Pharmaceuticals stands as a prominent global Contract Development and Manufacturing Organization (CDMO), serving the pharmaceutical, biotech, generic, and CDMO sectors. We specialize in providing regulatory starting materials (RSMs), intermediates, Active Pharmaceutical Ingredients (APIs), highly potent APIs, sterile APIs, and sterile drug product formulations to clients worldwide.
Our US-FDA inspected GMP-compliant manufacturing facilities, equipped with sterile suspension injectable manufacturing capabilities, ensure unmatched quality and compliance. With a dedicated drug product formulation research and development laboratory, we bolster our capabilities, particularly in complex injectables.
Agno Pharmaceuticals remains committed to investing in our workforce and infrastructure, offering a wide range of service capabilities across the entire drug development and commercialization process. Our track record underscores our proficiency, with a demonstrated history of delivering both development and commercial stage cGMP manufacturing solutions to clients in North America and Europe. Our team of seasoned industry experts specializes in complex drug product formulation development and manufacturing, drug implant development, and an array of supporting services. From analytical and physical characterization to cGMP clinical supply manufacturing, we present a diverse range of formulation development technologies.
Our adeptness in addressing challenges posed by poorly soluble and highly potent compounds, in both sterile and non-sterile environments, sets us apart from other CDMO service providers. Agno Pharmaceuticals is dedicated to exceeding our clients’ expectations at every stage of their journey. We are not just striving for this; it’s our steadfast commitment. With a tireless pursuit of excellence and innovation, we are prepared to meet the ever-changing demands of the pharmaceutical industry and enable our clients to achieve their goals.
Comprehensive CDMO Services
Agno Pharmaceuticals is a US-headquartered, premier global end-to-end CDMO that supports both innovative and generic sectors.
With approximately 500 employees, we offer comprehensive services, including formulation and analytical development for complex drug products, drug product cGMP commercial manufacturing, API process and analytical development, sterile API and sterile excipient manufacturing, and sterile injectable suspension and sterile powder fill cGMP manufacturing.
Commitment to Quality and Compliance
All members of our organization are fully committed to quality and compliance to ensure our services and products meeting the highest quality standards.
Our commitment to quality and compliance is unwavering. We have successfully passed US FDA inspections in 2014, 2018, 2020, 2021, and 2024 further reinforcing our dedication to maintaining the highest standards of regulatory compliance. Trust Agno Pharmaceuticals for all your CDMO needs and experience firsthand the impact of our expertise and unwavering dedication.
Agno Pharma is a member of DCAT. We honor and practice ChemStewardˇs core principles to ensure all our services and products are environmentally friendly.
Our Facilities
Our Principles
The owners and management team of Agno Pharma recognize that our company must earn the right to conduct business. We do not assume that this right is a given, but rather that it is possessed by those companies that, over time, show themselves to be founded upon a strong sense of decency and high ethical standards. Our strong sense of decency is rooted in the individual personal beliefs of the company’s owners, and it manifests itself in all of our relationships. These relationships include those within our own company, our employees, our community, our clients, our suppliers, our environment, and our country. Our ethical standards are the highest.
As we endeavor to conduct business, meet our fiscal goals, meet our personal goals and grow, we recognize and practice the following guiding principles: